Visa, American Express, or Mastercard?

The S&P 500 has yet to reach its levels from March 2008, but Visa Inc (NYSE:V) is up 117% from its IPO at that time including a 35% gain year to date. Visa also topped our list of the most popular services stocks among hedge funds for the second quarter of 2012 (see the full rankings) as 67 funds and other notable investors in our database of 13F filings reported a position in the stock. Two of these funds, which in fact increased their stakes during the quarter, are run by “Tiger Cubs”, former employees of Julian Robertson at Tiger Management (Robertson, in an interview about a year ago, had urged investors to buy credit card companies). Tiger Global Management, which is run by billionaire Chase Coleman and his team, owned 3 million shares (research more stocks that Tiger Global owns) while Andreas Halvorsen’s Viking Global moved heavily into the stock and closed June with 4.9 million shares in its portfolio (find more stock picks from Viking Global).

TIGER MANAGEMENT

The third quarter of Visa’s fiscal year ended in June with the company reporting a 10% increase in revenue compared to the third fiscal quarter of last year. This was actually a lower growth rate than what the company had been doing on the top line; revenue for the first nine months of the fiscal year was 13% higher than a year earlier. Visa took a large litigation charge during the quarter, which pulled operating income negative. Without that charge, operating income was up 11%, so the company is doing well at preserving margins as well as at growing its core business. Visa has also used less cash to buy back shares this fiscal year than it did last year, though this is reasonable given the increase in the share price since that time. While we think Visa should be able to continue its growth, we are wary of its forward P/E of 19- it is possible that the stock price is due for a correction.

The best peers for Visa are fellow credit card companies Mastercard Inc (NYSE:MA), Discover Financial Services (NYSE:DFS), American Express Company (NYSE:AXP), and Capital One Financial Corp. (NYSE:COF). Mastercard is probably the closest peer, and it trades at a similar valuation to Visa at 18 times forward earnings estimates. It also saw growth last quarter, with its revenue increasing 9% and its earnings increasing 15%. We think that Visa has a slightly better brand than Mastercard, and so should be trading at a slightly higher multiple given that its recent business performance has been about the same. That is exactly what we see, so we don’t think either of the two is overpriced relative to the other.

Visa and Mastercard are much more expensive than the other three companies, however. Discover, American Express, and Capital One carry forward P/Es of 10, 12, and 8, respectively. True, it can be argued that their brands are not as good as the market leaders- though followers of American Express would take exception to that- but that is a quite wide gap in valuation. In Capital One’s case, revenue and earnings are down from a year ago so it does make sense for the stock to be trading at a substantial discount. We would rather avoid it, but would note that it would be an excellent value if analyst expectations prove correct. American Express’s business has been about flat, and we think it is a better buy than Mastercard or Visa when taking into account its low multiples (its trailing P/E is only 14 as well). Discover appears to be even more undervalued. It trades at 10 times forward earnings estimates, as we’ve mentioned, and 9 times trailing earnings even after the 64% gain in the stock price from a year ago. This is because its business has been doing very well: its most recent quarterly report showed revenue up 30% and earnings up 36% from the same period in the previous year.

Visa seems about even with Mastercard, with the two likely not warranting such a high premium relative to other companies in the credit card industry. American Express appears to be a better value, and Discover would certainly be worth a closer look as well.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!